Elsevier expands biopharma base
Science and health publishing giant Elsevier has acquired Windhover Information Inc., a leading biotech and pharma business intelligence provider. linkurl:Windhover;http://www.windhover.com/dotcom/home.asp publishes several journals, such as __In Vivo__, __Start-up__ and __The Regulation Policy Market Access Report__, which cover health care marketplace trends, business strategy, industry deal making, and medical start-ups. Acquiring Windhover adds more than 100 journalists to Elsevier's staff


The Scientist ARCHIVES
Become a Member of
Meet the Author
Bob Grant
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.View full profile